OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 114, Issue 4, Pages 631-639 (April 2007)


View previous. 6 of 48 View next.

A Prospective Study of Endothelial Cell Loss during the 2 Years after Deep Lamellar Endothelial Keratoplasty

Presented in part as a paper at: American Academy of Ophthalmology Annual Meeting, October 17, 2005, Chicago, Illinois.

Mark A. Terry, MD12Corresponding Author Informationemail address, Jennifer M. Wall, BS2, Karen L. Hoar, MD, FRCSC1, Paula J. Ousley, MT2

Received 19 July 2006; accepted 24 November 2006.

Purpose

To report the endothelial survival over a 2-year period after 2 techniques of deep lamellar endothelial keratoplasty (DLEK) in the treatment of endothelial dysfunction.

Design

Prospective, noncomparative, interventional case series.

Participants

One hundred eyes of 88 patients with corneal edema.

Methods

One hundred consecutive eyes with endothelial failure were entered into a prospective study of endothelial keratoplasty, and the donor central endothelial cell density (ECD) was recorded postoperatively at 6 months (n = 98), 12 months (n = 96), and 24 months (n = 85) and then compared with the preoperative eye bank measurements. The subsets of eyes with large-incision DLEK (n = 36) and small-incision DLEK (n = 62) were also evaluated and compared.

Main Outcome Measures

Preoperative and postoperative central ECDs were prospectively evaluated and the cell loss calculated for each postoperative time point.

Results

The average (and standard deviation) ECD at 6 months was 2140±426 cells/mm2, representing a mean cell loss from preoperative donor cell measurements of 25±15%. At 12 months, ECD was 2090±448 cells/mm2 (26±16% cell loss), and at 24 months, it was 1794±588 cells/mm2 (37±27% cell loss). The additional cell loss from 1 to 2 years was significant (P<0.001). In the subset of large-incision DLEK eyes (n = 36), the cell loss from preoperatively to 6 months was 23%; 12 months, 22%; and 24 months, 27%. In the subset of small-incision DLEK eyes (n = 62), the cell loss from preoperatively to 6 months was 25%; 12 months, 28%; and 24 months, 43%. The cell loss from small-incision DLEK surgery was significantly greater than that from large-incision DLEK surgery at the 12-month (P = 0.013) and 24-month (P<0.001) postoperative measurements.

Conclusions

Although the initial cell loss from DLEK surgery is minimally changed from 6 to 12 months postoperatively, there is an acceleration of cell loss from 1 year to 2 years postoperatively. The small-incision DLEK technique, which involves folding of the donor tissue, results in a significantly higher endothelial cell loss at 1 and 2 years than that found after large-incision DLEK surgery, wherein the tissue is not folded.

1 Devers Eye Institute, Portland, Oregon.

2 Lions Vision Research Laboratory of Oregon, Portland, Oregon.

Corresponding Author InformationCorrespondence and reprint requests to Mark A. Terry, MD, Director, Corneal Services, Devers Eye Institute, 1040 NW 22nd Avenue, Portland, OR 97210.

 Manuscript no. 2006-801.

 Dr Terry has a financial interest in the specialized instruments used in the surgery. Bausch and Lomb Surgical manufactured and supplied the specially designed instruments free of charge.

 Supported by the Oregon Lions Sight and Hearing Foundation, Portland, Oregon.

PII: S0161-6420(06)01593-4

doi:10.1016/j.ophtha.2006.11.024


View previous. 6 of 48 View next.